David N. O’Dwyer

2.5k total citations
45 papers, 1.5k citations indexed

About

David N. O’Dwyer is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, David N. O’Dwyer has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 14 papers in Epidemiology and 10 papers in Molecular Biology. Recurrent topics in David N. O’Dwyer's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (26 papers), Gut microbiota and health (8 papers) and Pleural and Pulmonary Diseases (6 papers). David N. O’Dwyer is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (26 papers), Gut microbiota and health (8 papers) and Pleural and Pulmonary Diseases (6 papers). David N. O’Dwyer collaborates with scholars based in United States, Ireland and United Kingdom. David N. O’Dwyer's co-authors include Bethany B. Moore, Robert P. Dickson, Shanna L. Ashley, Michelle E. Armstrong, Seamas C. Donnelly, Stephen J. Gurczynski, Susan Murray, Gordon Cooke, Meng Xia and Katy C. Norman and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

David N. O’Dwyer

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David N. O’Dwyer United States 19 866 473 291 270 175 45 1.5k
Michal Shteinberg Israel 22 1.3k 1.5× 475 1.0× 296 1.0× 177 0.7× 106 0.6× 110 2.2k
Shanna L. Ashley United States 16 464 0.5× 390 0.8× 169 0.6× 116 0.4× 126 0.7× 20 988
Lindsay Schmidt United States 15 604 0.7× 595 1.3× 298 1.0× 177 0.7× 91 0.5× 27 1.5k
J Hull United Kingdom 12 609 0.7× 193 0.4× 457 1.6× 204 0.8× 271 1.5× 22 1.3k
Tomoyuki Kakugawa Japan 23 1.1k 1.3× 285 0.6× 484 1.7× 321 1.2× 164 0.9× 95 1.9k
Volker Stephan Germany 18 361 0.4× 264 0.6× 410 1.4× 471 1.7× 345 2.0× 39 1.6k
Kym Pham Australia 9 320 0.4× 458 1.0× 321 1.1× 297 1.1× 114 0.7× 11 1.1k
Yasuyuki Yoshizawa Japan 23 1.4k 1.7× 153 0.3× 253 0.9× 400 1.5× 207 1.2× 110 1.9k
Julia Aniscenko United Kingdom 13 656 0.8× 199 0.4× 433 1.5× 561 2.1× 420 2.4× 17 1.4k
Daniel H. Sterman United States 18 1.3k 1.5× 386 0.8× 113 0.4× 112 0.4× 204 1.2× 42 1.9k

Countries citing papers authored by David N. O’Dwyer

Since Specialization
Citations

This map shows the geographic impact of David N. O’Dwyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. O’Dwyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. O’Dwyer more than expected).

Fields of papers citing papers by David N. O’Dwyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. O’Dwyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. O’Dwyer. The network helps show where David N. O’Dwyer may publish in the future.

Co-authorship network of co-authors of David N. O’Dwyer

This figure shows the co-authorship network connecting the top 25 collaborators of David N. O’Dwyer. A scholar is included among the top collaborators of David N. O’Dwyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. O’Dwyer. David N. O’Dwyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jennifer M., Ayodeji Adegunsoye, Janelle Vu Pugashetti, et al.. (2025). A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 211(10). 1785–1793. 1 indexed citations
2.
Ranjan, Piyush, et al.. (2024). The Lung Microbiome. The Journal of Immunology. 212(8). 1269–1275. 9 indexed citations
3.
Gurczynski, Stephen J., Shafiul Alam, Biao Hu, et al.. (2023). Horizontal transmission of gut microbiota attenuates mortality in lung fibrosis. JCI Insight. 9(1). 11 indexed citations
4.
O’Dwyer, David N., John S. Kim, Shwu‐Fan Ma, et al.. (2023). Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease. American Journal of Respiratory and Critical Care Medicine. 209(9). 1101–1110. 12 indexed citations
5.
6.
Invernizzi, Rachele, Mohammad Doroudian, Mohsen Moghoofei, et al.. (2022). Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 205(5). 550–562. 16 indexed citations
7.
Gurczynski, Stephen J., David N. O’Dwyer, Rachel L. Zemans, et al.. (2022). Myeloid- and Epithelial-Derived Heparin-Binding Epidermal Growth Factor-like Growth Factor Promotes Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 67(6). 641–653. 16 indexed citations
8.
Chotirmall, Sanjay H., Debby Bogaert, James D. Chalmers, et al.. (2022). Therapeutic Targeting of the Respiratory Microbiome. American Journal of Respiratory and Critical Care Medicine. 206(5). 535–544. 41 indexed citations
9.
Barker, Anna, et al.. (2022). Hemidiaphragm Paralysis Caused by Phrenic Nerve Neurofibroma. Annals of the American Thoracic Society. 20(1). 136–139. 1 indexed citations
10.
Murray, Susan, et al.. (2022). Fibrotic Lung Disease Alters Neutrophil Trafficking and Promotes Neutrophil Elastase and Extracellular Trap Release. ImmunoHorizons. 6(12). 817–834. 19 indexed citations
11.
Falkowski, Nicole R., Gary B. Huffnagle, John R. Erb‐Downward, et al.. (2021). Toll-like receptors, environmental caging, and lung dysbiosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 321(2). L404–L415. 9 indexed citations
12.
Moore, Bethany B., et al.. (2020). The evolving role of the lung microbiome in pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 319(4). L675–L682. 25 indexed citations
13.
Zhou, Xiaofeng, David N. O’Dwyer, Meng Xia, et al.. (2019). First-Onset Herpesviral Infection and Lung Injury in Allogeneic Hematopoietic Cell Transplantation. American Journal of Respiratory and Critical Care Medicine. 200(1). 63–74. 28 indexed citations
14.
Clemente, José C., Michael J. Cox, Robert P. Dickson, et al.. (2019). Methods in Lung Microbiome Research. American Journal of Respiratory Cell and Molecular Biology. 62(3). 283–299. 104 indexed citations
15.
O’Dwyer, David N., Shanna L. Ashley, Stephen J. Gurczynski, et al.. (2019). Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 199(9). 1127–1138. 220 indexed citations
16.
Norman, Katy C., Bethany B. Moore, Kelly B. Arnold, & David N. O’Dwyer. (2018). Proteomics: Clinical and research applications in respiratory diseases. Respirology. 23(11). 993–1003. 18 indexed citations
17.
O’Dwyer, David N., Shanna L. Ashley, & Bethany B. Moore. (2016). Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 311(3). L590–L601. 73 indexed citations
18.
Ashley, Shanna L., Meng Xia, Susan Murray, et al.. (2016). Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF. PLoS ONE. 11(8). e0159878–e0159878. 37 indexed citations
19.
Gurczynski, Stephen J., Megan C. Procario, David N. O’Dwyer, Carol A. Wilke, & Bethany B. Moore. (2016). Loss of CCR2 signaling alters leukocyte recruitment and exacerbates γ-herpesvirus-induced pneumonitis and fibrosis following bone marrow transplantation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 311(3). L611–L627. 19 indexed citations
20.
O’Dwyer, David N., Michelle E. Armstrong, Glenda Trujillo, et al.. (2013). The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 188(12). 1442–1450. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michal Shteinberg Breakdown of academic impact, for papers by Shanna L. Ashley Breakdown of academic impact, for papers by Lindsay Schmidt Breakdown of academic impact, for papers by J Hull Breakdown of academic impact, for papers by Tomoyuki Kakugawa Breakdown of academic impact, for papers by Volker Stephan Breakdown of academic impact, for papers by Kym Pham Breakdown of academic impact, for papers by Yasuyuki Yoshizawa Breakdown of academic impact, for papers by Julia Aniscenko Breakdown of academic impact, for papers by Daniel H. Sterman
Rankless by CCL
2026